论文信息 - Discovery and early clinical evaluation of BMS-605339, a potent and orally efficacious tripeptidic acylsulfonamide NS3 protease inhibitor for the treatment of hepatitis C virus infection. - 字舞流文

Discovery and early clinical evaluation of BMS-605339, a potent and orally efficacious tripeptidic acylsulfonamide NS3 protease inhibitor for the treatment of hepatitis C virus infection.

A. Good | H. Klei | A. Cocuzza | N. Meanwell | R. Colonno | Chaoqun Chen | D. Grasela | J. Thuring | S. Adams | R. Rajamani | P. Levesque | P. Falk | T. Zvyaga | J. Knipe | A. Sheaffer | Jianqing Li | F. Mcphee | E. Hughes | P. Scola | Yong-Hae Han | C. Gesenberg | Min Ding | M. Sinz | Yong Tu | N. Sin | B. Venables | Qi Gao | S. Sit | Jie Chen | Yan Chen | S. Jenkins | Wenying Li | D. Hernandez | Danshi Li | Donna M. Bilder | K. Santone | A. Wang | S. D'Andrea | P. Hewawasam | D. Barry | Li-Qiang Sun | B. Zheng | G. Zhai | Fei Yu | Min S. Lee | K. Combrink | J. Campbell | Jialong Zhu | C. Chien | Yong‐Hae Han